Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

China · Delayed Price · Currency is CNY

9.45

+0.04 (0.43%)

Mar 6, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Manufacturing	470.21M	825.29M	384.52M	475.20M	680.35M
Pharmaceutical Manufacturing Growth	-43.02%	114.63%	-19.08%	-30.15%	-8.74%
Chinese Herbal Medicines	963.46M	744.75M	924.37M	1.21B	1.10B
Chinese Herbal Medicines Growth	29.37%	-19.43%	-23.54%	10.01%	-4.13%
Others	406.37M	351.47M	273.85M	170.50M	476.02M
Others Growth	15.62%	28.35%	60.61%	-64.18%	390.82%
Medical Instruments	20.42M	17.42M	16.20M	14.80M	14.05M
Medical Instruments Growth	17.21%	7.51%	9.44%	5.35%	-8.13%
Pharmaceutical Distribution	324.16M	360.36M	588.12M	868.86M	618.24M
Pharmaceutical Distribution Growth	-10.04%	-38.73%	-32.31%	40.54%	-4.22%
Offset of Business Segment	-325.96M	-	-	-	-
Soft Drinks	-	-	-	232.26M	184.52M
Soft Drinks Growth	-	-	-	25.87%	35.03%
Total	1.86B	2.30B	2.19B	2.97B	3.07B
Total Growth	-19.16%	5.13%	-26.38%	-3.30%	10.26%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Guangdong Province	413.14M	737.28M	555.58M	827.68M	1.06B
Guangdong Province Growth	-43.96%	32.70%	-32.87%	-22.17%	34.54%
Southwest Region	71.82M	110.03M	110.14M	86.67M	218.53M
Southwest Region Growth	-34.72%	-0.10%	27.08%	-60.34%	65.50%
Central China	99.95M	219.38M	727.16M	1.18B	984.02M
Central China Growth	-54.44%	-69.83%	-38.63%	20.41%	-7.67%
Northern China, Eastern China, and The Northeastern China	1.27B	1.23B	794.19M	871.37M	798.43M
Northern China, Eastern China, and The Northeastern China Growth	3.34%	55.20%	-8.86%	9.14%	1.77%
Overseas	-	-	-	-	7.71M
Overseas Growth	-	-	-	-	-42.51%
Total	1.86B	2.30B	2.19B	2.97B	3.07B
Total Growth	-19.16%	5.13%	-26.38%	-3.30%	10.26%

Source: S&P Global Market Intelligence.